See also this year's filing and all EDGAR filings for this company.
PDF Report 0001694665_2022_Evelo_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001694665')"} |
Graph
Absolute values for 0001694665, Evelo Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 71,026,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,622,000 |
| 3 | remainder_Assets | 10,223,000 |
| 4 | LiabilitiesCurrent | 17,362,000 |
| 5 | LiabilitiesNoncurrent | 54,342,000 |
| 6 | remainder_Liabilities | 7,500,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,753,000 |
| 9 | ResearchAndDevelopmentExpense | 83,643,000 |
| 10 | remainder_Expenses | 428,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -6,352,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 87,871,000 |
| 1 | Liabilities | 79,204,000 |
| 2 | Expenses | 115,824,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 8,667,000 |
| 5 | NetIncome | -122,176,000 |
| 6 | ComprehensiveNetIncome | -122,176,000 |
| 7 | BaseVar | 144,625,500 |
| 8 | EconomicCapitalRatio | -1.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
